Alerten Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Side Effects Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Coenzyme Q10

Indications/Uses

25 mg: Supportive treatment for patients w/ CHF. 50 mg: Periodontal disease. Prevention of coenzyme Q10 depletion in concomitant use w/ HMG-CoA reductase inhibitor. Adjunctive therapy for CHF.

Click to view Alerten detailed prescribing information

Dosage/Direction for Use

25 mg 1 cap daily. 50 mg 1-2 cap bd-tds.

Click to view Alerten detailed prescribing information

Administration

Should be taken with food.

Contraindications

Severe liver or kidney disease. Pregnancy & lactation. Childn.

Click to view Alerten detailed prescribing information

Special Precautions

May decrease warfarin effectiveness.

Click to view Alerten detailed prescribing information

Adverse Reactions

Nausea, diarrhea & epigastric distress particularly w/ higher doses (≥200 mg daily).

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Alerten detailed prescribing information

Storage

View Alerten storage conditions for details to ensure optimal shelf-life.

Description

View Alerten description for details of the chemical structure and excipients (inactive components).

Action

View Alerten mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Cardiovascular Drugs

ATC Classification

C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.

Regulatory Classification

POM

Presentation/Packing

Form

Alerten softgel cap 25 mg

Packing/Price

3 × 10's

Form

Alerten softgel cap 50 mg

Packing/Price

3 × 10's

Alerten

ubidecarenone

Manufacturer:

Mega Lifesciences

Distributor:

Maxxcare